These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31751940)

  • 1. Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators.
    Mulder K
    Int J Pharm Compd; 2019; 23(6):447-452. PubMed ID: 31751940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets.
    Mulder K
    Int J Pharm Compd; 2020; 24(1):7-12. PubMed ID: 32023210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrier isolators as an alternative to a cleanroom.
    Tillett L
    Am J Health Syst Pharm; 1999 Jul; 56(14):1433-6. PubMed ID: 10428451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aseptic simulation test for cytotoxic drug production in isolators.
    Savry A; Correard F; Bennis Y; Roubaud S; Gauthier-Villano L; Pisano P; Pourroy B
    Am J Health Syst Pharm; 2014 Mar; 71(6):476-81. PubMed ID: 24589539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic assessment of aseptic compounding rooms in hospital pharmacies in five European countries.
    Dekyndt B; Décaudin B; Lannoy D; Odou P
    J Oncol Pharm Pract; 2015 Apr; 21(2):102-10. PubMed ID: 24519187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating containment effectiveness of A2 and B2 biological safety cabinets.
    Taylor AV; Baker N; Hulsey M; Bennett CC; Meiners M; Gonzales BA
    Am J Health Syst Pharm; 2019 Apr; 76(9):599-607. PubMed ID: 31361829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAFER STERILE COMPOUNDING: Choosing and Using Disinfectants for the Cleanroom.
    Kastango ES; Douglass K; Patel K; Givehchi B; Brister P; Postlewaite J; Taraban L
    Int J Pharm Compd; 2015; 19(4):268-78. PubMed ID: 26625562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ultraviolet irradiation efficacy in an automated system for the aseptic compounding using challenge test.
    Bruscolini F; Paolucci D; Rosini V; Sabatini L; Andreozzi E; Pianetti A
    Int J Qual Health Care; 2015 Oct; 27(5):412-7. PubMed ID: 26233490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Certification of Powder-containment Hoods for Nonsterile Compounding.
    Mulder K; Dozzi R
    Int J Pharm Compd; 2018; 22(5):369-384. PubMed ID: 30384336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and content validation of an assessment tool for medicine compounding on hospital wards.
    Suvikas-Peltonen E; Granfors E; Celikkayalar E; Laaksonen R; Palmgren J; Airaksinen M
    Int J Clin Pharm; 2016 Dec; 38(6):1457-1463. PubMed ID: 27817169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evaluation of the Containment Efficacy of Semi-Rigid Isolators for Housing Cages of Laboratory Animals Infected With BSL-3 Agents.
    DeTolla L; Johnson DK; Reynolds SD; Sanchez R; Weichbrod RH; Terzi MC
    ILAR J; 2022 Jan; 61(1):40-45. PubMed ID: 34161585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
    Geersing TH; Franssen EJF; Pilesi F; Crul M
    Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sampling for airborne fluorouracil in a hospital drug preparation area.
    McDiarmid MA; Egan T; Furio M; Bonacci M; Watts SR
    Am J Hosp Pharm; 1986 Aug; 43(8):1942-5. PubMed ID: 3752134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Aseptic Compounding Errors Before and After Modified Laboratory and Introductory Pharmacy Practice Experiences.
    Dennis VC; Owora AH; Kirkpatrick AE
    Am J Pharm Educ; 2015 Dec; 79(10):158. PubMed ID: 26889070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BASICS OF STERILE COMPOUNDING: Barrier Isolator Technologies in Aseptic Processing.
    Akers MJ
    Int J Pharm Compd; 2015; 19(4):315-20. PubMed ID: 26625569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic preparation time in a horizontal laminar-airflow hood and in a biological-safety cabinet.
    Hamm JL; Daniels CE; Somani SM
    Am J Hosp Pharm; 1984 Jul; 41(7):1349-51. PubMed ID: 6465149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.